ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: Chronic myeloid leukemia (CML) is characterized by a BCR–ABL1 fusion protein, originating from the translocation between chromosome 9 and 22 (t(9;22)), which is also the molecular marker for the evaluation of the minimal residual disease (MRD) in CML [1].